Detalhe da pesquisa
1.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
2.
Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma.
Cancer
; 121(13): 2185-92, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809731
3.
Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Invest New Drugs
; 32(3): 489-99, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24352795
4.
The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
J Biol Chem
; 287(39): 32875-80, 2012 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22898820
5.
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
Hematol Oncol
; 35(4): 914-917, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402335
6.
Complete Response to R-EPOCH in Primary Cardiac Lymphoma.
Case Rep Hematol
; 2019: 7690430, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31214365
7.
Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.
Clin Cancer Res
; 24(24): 6150-6159, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30082475
8.
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Clin Cancer Res
; 22(4): 868-76, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26459177
9.
Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias.
Cancer Chemother Pharmacol
; 72(4): 897-908, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23949430